Pharmac agrees to fund drug for those with spinal muscular atrophy after years of lobbying

+News

Pharmac agrees to fund drug for those with spinal muscular atrophy after years of lobbying

RNZ

RNZ

Wheelchair child CR Jon Tyson via Unsplash
Nusinersen (branded as Spinraza) would be the first medicine publicly funded for people who have spinal muscular atrophy [Image Jon Tyson via Unsplash]
New medicines for those with a rare spinal disease and people at risk of anaphylaxis are set to be publicly funded. Pharmac is looking at funding a